Next Article in Journal / Special Issue
MicroRNAs as Biomarkers in Cancer
Previous Article in Journal
A Review of Heating and Temperature Control in Microfluidic Systems: Techniques and Applications
Previous Article in Special Issue
Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma
Diagnostics 2013, 3(1), 68-83; doi:10.3390/diagnostics3010068
Article

TD-GC-MS Investigation of the VOCs Released from Blood Plasma of Dogs with Cancer

1
, 1
, 2
, 3
 and 1,*
Received: 8 December 2012; in revised form: 31 December 2012 / Accepted: 15 January 2013 / Published: 16 January 2013
(This article belongs to the Special Issue Molecular Biomarkers for Cancer Targeted Therapeutics)
View Full-Text   |   Download PDF [474 KB, uploaded 16 January 2013]   |   Browse Figures
Abstract: An analytical TD-GC-MS method was developed and used for the assessment of volatile organic compounds (VOCs) released from the blood plasma of dogs with/without cancer. VOCs released from 40 samples of diseased blood and 10 control samples were compared in order to examine the difference between both sample groups that were showing qualitatively similar results independent from the disease’s presence. However, mild disturbances in the spectra of dogs with cancer in comparison with the control group were observed, and six peaks (tentatively identified by comparison with mass spectral library as hexanal, octanal, toluene, 2-butanone, 1-octen-3-ol and pyrrole) revealed statistically significant differences between both sample groups, thereby suggesting that these compounds are potential biomarkers that can be used for cancer diagnosis based on the blood plasma TD-GC-MS analysis. Statistical comparison with the application of principal component analysis (PCA) provided accurate discrimination between the cancer and control groups, thus demonstrating stronger biochemical perturbations in blood plasma when cancer is present.
Keywords: dog blood plasma; TD-GC-MS; volatile organic compounds; cancer markers dog blood plasma; TD-GC-MS; volatile organic compounds; cancer markers
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Selyanchyn, R.; Nozoe, T.; Matsui, H.; Kadosawa, T.; Lee, S.-W. TD-GC-MS Investigation of the VOCs Released from Blood Plasma of Dogs with Cancer. Diagnostics 2013, 3, 68-83.

AMA Style

Selyanchyn R, Nozoe T, Matsui H, Kadosawa T, Lee S-W. TD-GC-MS Investigation of the VOCs Released from Blood Plasma of Dogs with Cancer. Diagnostics. 2013; 3(1):68-83.

Chicago/Turabian Style

Selyanchyn, Roman; Nozoe, Takuma; Matsui, Hidetaka; Kadosawa, Tsuyoshi; Lee, Seung-Woo. 2013. "TD-GC-MS Investigation of the VOCs Released from Blood Plasma of Dogs with Cancer." Diagnostics 3, no. 1: 68-83.


Diagnostics EISSN 2075-4418 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert